Search

everythinglearnresearchcommunity

for

Search:↓

The framework helps predict adverse effects of blood thinners, improving drug selection for atrial fibrillation.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

The nanoparticles improved minoxidil's skin absorption, making them promising for skin treatments.

Combining oral minoxidil with JAK inhibitors helps regrow hair in severe alopecia areata cases.

Flubendazole in a nanoemulsion can potentially treat lung cancer and cryptococcal meningitis effectively and safely.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Topical tofacitinib may help regrow hair in children with alopecia totalis.

Tedisamil and glibenclamide affect cromakalim and minoxidil sulphate differently in rat aorta.

Gefitinib can cause hair loss without scarring.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Mycophenolate mofetil may safely help restore skin color in depigmentation conditions.

Janus kinase inhibitors may effectively treat resistant scalp conditions like folliculitis decalvans and dissecting cellulitis.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Uveal melanoma is hard to treat when it spreads, but a new drug, tebentafusp, helps patients live longer.

Bicalutamide may be a promising alternative treatment for female pattern hair loss.

Identical p53 gene mutations in different cancers suggest the need for careful treatment.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

Increased pigmentation may protect skin from UVB, new targets for skin disease treatments were identified, sunscreen ingredients don't affect hormones, TNF-α inhibitors may help diabetic wounds, and certain treatments could prevent chemotherapy-induced hair loss.

Upadacitinib may effectively treat resistant lichen planopilaris.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Simvastatin/ezetimibe may help treat new cases of alopecia areata but not long-term cases.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.